These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8422647

  • 1. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
    Levine AE, Lewis LR.
    Cancer Lett; 1993 Jan 15; 68(1):33-41. PubMed ID: 8422647
    [Abstract] [Full Text] [Related]

  • 2. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE, Black B, Brattain MG.
    J Cell Physiol; 1989 Mar 15; 138(3):459-66. PubMed ID: 2925796
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG.
    Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA, Ziober BL, Morris SL, Mulder KM.
    Cell Growth Differ; 1993 Aug 01; 4(8):637-45. PubMed ID: 8398905
    [Abstract] [Full Text] [Related]

  • 5. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J.
    Cancer Res; 1989 Apr 15; 49(8):2112-7. PubMed ID: 2539253
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM, Infante D, Winawer S, Friedman E.
    Cell Growth Differ; 1990 Dec 15; 1(12):617-26. PubMed ID: 2288877
    [Abstract] [Full Text] [Related]

  • 7. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells.
    Mulder KM, Brattain MG.
    Int J Cancer; 1988 Jul 15; 42(1):64-70. PubMed ID: 3164710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
    Marks ME, Ziober BL, Brattain MG.
    Cancer Res; 1986 Oct 15; 46(10):5248-58. PubMed ID: 3756877
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG.
    Cancer Lett; 1988 Jun 15; 40(2):219-32. PubMed ID: 3164250
    [Abstract] [Full Text] [Related]

  • 11. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S, Huang F, Hafez M, Winawer S, Friedman E.
    Cell Growth Differ; 1994 Mar 15; 5(3):267-75. PubMed ID: 8018559
    [Abstract] [Full Text] [Related]

  • 12. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
    Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7120-5. PubMed ID: 3191488
    [Abstract] [Full Text] [Related]

  • 13. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM.
    Cell Growth Differ; 1990 Aug 15; 1(8):367-74. PubMed ID: 2177634
    [Abstract] [Full Text] [Related]

  • 14. Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines.
    Watkins LF, Brattain MG, Levine AE.
    Cancer Lett; 1988 May 15; 40(1):59-70. PubMed ID: 3259465
    [Abstract] [Full Text] [Related]

  • 15. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S, Tobon A, Varani J, Brattain MG.
    Cancer Res; 1988 Jul 15; 48(14):4059-64. PubMed ID: 3289738
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
    Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG.
    J Cell Biol; 1992 Jan 15; 116(1):187-96. PubMed ID: 1730743
    [Abstract] [Full Text] [Related]

  • 17. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L, Wu S, Coleman K, Fields KC, Humphrey LE, Brattain MG.
    Exp Cell Res; 1994 Sep 15; 214(1):215-24. PubMed ID: 8082724
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E.
    Cell Growth Differ; 1995 Dec 15; 6(12):1635-42. PubMed ID: 9019169
    [Abstract] [Full Text] [Related]

  • 19. Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1.
    Chakrabarty S.
    Int J Cancer; 1992 Apr 01; 50(6):968-73. PubMed ID: 1555895
    [Abstract] [Full Text] [Related]

  • 20. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, Brattain MG.
    Cell Growth Differ; 1993 Feb 01; 4(2):115-23. PubMed ID: 8494782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.